SCHEMBL1900699

SCHEMBL1900699

NCCSS

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cystamine SCHEMBL2832694 0.89 TSHR (0.67)
SCHEMBL25083207 0.79
SCHEMBL6035009 0.77
SCHEMBL14939680 0.74
SCHEMBL4783396 0.67
SCHEMBL2698498 0.67
Cystamine SCHEMBL3648870 0.64 TSHR (1.00)
SCHEMBL50767 0.64
Cystamine SCHEMBL11040994 0.64
Cystamine SCHEMBL43866 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 92 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110124054-A1 Methods And Compositions For Inhibiting Undesired Cleaving Of Labels INTELLIGENT BIO-SYSTEMS, INC. 2011-05-26 US claimed
US-6136313-A ALKYLATION; REDUCTION AT LOW PH IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) 2000-10-24 US claimed
JP-58013563-A None JP disclosed
US-20260139060-A1 METHODS OF PRODUCING HETERODIMERIC ANTIBODIES GENMAB AS (DK) 2026-05-21 US disclosed
US-12415859-B2 Methods of producing heterodimeric antibodies GENMAB A/S (DK) 2025-09-16 US disclosed
US-12227798-B2 Methods and compositions for incorporating nucleotides IsoPlexis Corporation (US) 2025-02-18 US disclosed
US-20250052717-A1 METHODS AND DEVICES FOR SEQUENCING NUCLEIC ACIDS IN SMALLER BATCHES QIAGEN SCIENCES, LLC 2025-02-13 US disclosed
EP-4447944-A1 COMPOSITIONS AND METHODS FOR TARGETED DELIVERY OF THERAPEUTIC AND/OR DIAGNOSTIC SPECIES THE PENN STATE RESEARCH FOUNDATION (US) 2024-10-23 EP disclosed
US-20240335540-A1 COMPOSITIONS AND METHODS FOR TARGETED DELIVERY OF THERAPEUTIC AND/OR DIAGNOSTIC SPECIES PENN STATE RES FOUND (US) 2024-10-10 US disclosed
CN-118613287-A Compositions and methods for targeted delivery of therapeutic and/or diagnostic substances 宾夕法尼亚州立大学研究基金会 2024-09-06 CN disclosed
US-11940413-B2 Methods and devices for sequencing nucleic acids in smaller batches IsoPlexis Corporation (US) 2024-03-26 US disclosed
US-5075454-A Chemical intermediate, antitumor agent BRISTOL-MYERS SQUIBB COMPANY (US) 1991-12-24 US disclosed
EP-0445813-A1 7-(Diphenylmethyl)oxy-9a-methoxymitosane and the preparation and use thereof Bristol-Myers Squibb Company (US) 1991-09-11 EP disclosed
EP-0196174-B1 MEANS FOR SEQUENTIAL SOLID PHASE ORGANIC SYNTHESIS AND METHODS USING THE SAME SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) 1990-01-17 EP disclosed
US-4803212-A ANTITUMOR AGENTS BRISTOL-MYERS COMPANY (US) 1989-02-07 US disclosed
US-4691023-A MITOMYCIN ANALOGS-ANTITUMOR AGENTS BRISTOL-MYERS COMPANY (US) 1987-09-01 US disclosed
US-4631211-A REACTIVE PARTICLES ENCLOSED IN WATER AND SOLVENT-INSOLUBLE MESH CONTAINER; PEPTIDE SYNTHESIS SCRIPPS CLINIC & RESEARCH FOUNDATION (US) 1986-12-23 US disclosed
EP-0196174-A2 Means for sequential solid phase organic synthesis and methods using the same SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) 1986-10-01 EP disclosed
JP-S5813563-A PURIFICATION AND SEPARATION OF 2-AMINOETHANETHIOL HYDROHALIDES MITSUI TOATSU CHEM INC 1983-01-26 JP disclosed
US-4346247-A Method and catalyst for making bisphenol GENERAL ELECTRIC COMPANY (US) 1982-08-24 US disclosed